Farzaneh Tofighi Zavareh

The Anti-tumoral Effect of β-D-Mannuronic Acid (M2000) as a Novel NSAID on Treg Cells Frequency and MMP-2, MMP-9, CCL22 and TGFβ1 Gene Expression in Pre-surgical Breast Cancer Patients.

H. Mahmoodzadeh, R. Omranipour, H. Ahmadi, 2019, Iranian journal of allergy, asthma, and immunology.

Preclinical and pharmacotoxicology evaluation of α-l-guluronic acid (G2013) as a non-steroidal anti-inflammatory drug with immunomodulatory property

M. Abdollahi, R. Sedaghat, Farzaneh Tofighi Zavareh, 2017, Immunopharmacology and immunotoxicology.

Preclinical assessment of β-d-mannuronic acid (M2000) as a non-steroidal anti-inflammatory drug

M. Abdollahi, R. Sedaghat, N. Rastkari, 2015, Immunopharmacology and immunotoxicology.

An in vitro assessment for evaluating the efficiency of β‐d‐mannuronic acid (M2000) in myelodysplastic syndrome

F. Jafarnezhad‐Ansariha, Farzaneh Tofighi Zavareh, A. Mirshafiey, 2018, Journal of cellular physiology.

Immunophenotypic and functional analysis of lymphocyte subsets in common variable immunodeficiency patients without monogenic defects

N. Rezaei, A. Aghamohammadi, A. Keshtkar, 2022, Scandinavian journal of immunology.

Effects of imatinib mesylate in mouse models of multiple sclerosis and in vitro determinants.

M. Khorramizadeh, R. Sedaghat, G. Azizi, 2014, Iranian journal of allergy, asthma, and immunology.

Efficacy and Safety of G2013 as a Novel Immunosuppressive Agent on Differentiation, Maturation and Function of Human Dendritic Cells

J. Hadjati, Farzaneh Tofighi Zavareh, A. Mirshafiey, 2017, Iranian journal of public health.

Lymphocytes subsets in correlation with clinical profile in CVID patients without monogenic defects

N. Rezaei, A. Aghamohammadi, A. Keshtkar, 2021, Expert review of clinical immunology.